Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Paraganglioma × NET × Clear all

Phase

Phase 2 8 Phase 1/2 4 Phase 1 3 Phase EARLY_PHASE1 1 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Endocrine 2 CNS 2 NET 1

Conditions

Neuroendocrine Tumors 16 von Hippel-Lindau Disease 1 Pheochromocytoma 1 Paraganglioma 1 Neuroblastoma 1 Multiple Endocrine Neoplasia Type 1 1 Meningioma 1 Lung Neoplasms 1 Gastro-enteropancreatic neuroendocrine tumor 1 Carcinoid Tumor 1

Interventions

gallium Ga 68 dotatate 1 3-fluorobenzylguanidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05069220 2024-03-01

18F-MFBG PET/CT in the Evaluation of Neural Crest Tumor

Peking Union Medical College Hospital

Phase EARLY_PHASE1 Recruiting

CNSEndocrineNET

Neuroblastoma, Paraganglioma, Pheochromocytoma, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡